News archive search

Search the Newsreel

Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.

Showing
37–40
Matches
40
Sources here
4
Companies here
1
Search results Stored financial headlines

Active search

40 matching headlines

Ticker or company: GHRSMain company stories
Clear

Search results

Matching headlines

External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.

24/7 Wall St. Market update Main company 🇺🇸 United States

GH Research : GHRS

This article provides an overview of GH Research PLC (GHRS), a Dublin-based biopharmaceutical company specializing in treatments for psychiatric and neurological disorders using 5-Methoxy-N,N-Dimethyltryptamine (5-MeO-DMT) therapies, particularly for treatment-resistant depression. It highlights their lead product GH001, an inhalable therapy in early clinical trials, and …

GHRS main company
Sharemaestro market context Trend signal active 52 weeks +125.5% GHRS stored weekly price path from 22 Aug 2025 to 14 Aug 2026
Benzinga Deals and strategy Main company 🇺🇸 United States

Why Is GH Research Stock Trading Higher on Thursday?

GH Research (GHRS) stock is trading higher due to Eli Lilly's agreement to acquire AtaiBeckley Inc. (ATAI) for up to $3.8 billion. GH Research's lead drug, GH001, is being compared to AtaiBeckley’s BPL-003, both targeting treatment-resistant depression with similar active compounds. The FDA recently …

GHRS main company
Sharemaestro market context Trend signal active 52 weeks +125.5% GHRS stored weekly price path from 22 Aug 2025 to 14 Aug 2026
Sahm Earnings Main company 🇺🇸 United States

GH Research (GHRS) In Focus As FDA Psychedelic Shift Raises The Question Of Value

The FDA's recent guidance on psychedelic drug development has significantly boosted GH Research (GHRS) stock, with its share price up over 100% year-to-date. Despite this surge, the company's valuation, evidenced by a 7x price-to-book ratio, appears expensive compared to its peers and the broader …

GHRS main company
Sharemaestro market context Trend signal active 52 weeks +125.5% GHRS stored weekly price path from 22 Aug 2025 to 14 Aug 2026
Market source Deals and strategy Main company 🇺🇸 United States

GH Research gains on optimism surrounding potential Eli Lilly-Atai deal (GHRS)

GH Research (GHRS) shares rose about 12% following reports that Eli Lilly is discussing acquiring Atai Life Sciences (ATAI), a psychedelic drug developer. This news boosted the entire psychedelic medicines sector, as investors anticipate increased pharmaceutical interest in such treatments. RBC Capital Markets highlighted …

GHRS main company
Sharemaestro market context Trend signal active 52 weeks +125.5% GHRS stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Find financial news

Search the Newsreel

Use one field or combine several. Results are newest first.

Evidence context